Treatment of coronary artery perforations complicating percutaneous coronary intervention with a

Alexandra J Lansky1, Yi-ming Yang, Yosef Khan

  • 1Cardiovascular Research Foundation, New York, New York, USA. alansky@crf.org

Insights

Coronary artery perforation during PCI is serious. A polytetrafluoroethylene-coated stent graft (CSG) effectively sealed perforations in a large multicenter study, avoiding major adverse events.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Research
  • Medical Device Technology

Background:

  • Coronary artery perforation is a rare but severe complication of percutaneous coronary intervention (PCI).
  • Traditional treatments for coronary perforation carry high risks of mortality, myocardial infarction, and emergency surgery.
  • Limited data exists on the efficacy of stent grafts for sealing coronary perforations.

Purpose of the Study:

  • To evaluate the outcomes of using the JOSTENT coronary stent graft (CSG) in patients with coronary artery perforations.
  • To assess the safety and effectiveness of CSG in managing severe coronary perforations complicating PCI.

Main Methods:

  • A retrospective analysis of an international registry involving 41 patients with coronary perforations.
  • Polytetrafluoroethylene-coated JOSTENT coronary stent grafts (CSGs) were used to treat the perforations.
  • Outcomes including perforation sealing, procedural success, and in-hospital complications were analyzed.

Main Results:

  • The study included severe perforations (29.1% Ellis grade 3).
  • 52 CSGs were successfully deployed in 41 patients, sealing 92.9% of perforations completely and 7.1% partially.
  • The overall procedure success rate was 96.4%, with no in-hospital Q-wave myocardial infarctions, emergency bypass surgeries, or deaths.

Conclusions:

  • The polytetrafluoroethylene-coated JOSTENT coronary stent graft (CSG) is a reliable and highly effective option for sealing coronary perforations.
  • CSG implantation significantly reduces the risk of severe complications associated with coronary artery perforation during PCI.
  • This multicenter series supports the use of CSG as a primary treatment for coronary perforations.

Related Concept Videos

Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...